BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behl T, Kumar S, Sehgal A, Singh S, Sharma N, Chirgurupati S, Aldubayan M, Alhowail A, Bhatia S, Bungau S. Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D. Biochem Biophys Res Commun 2021;583:14-21. [PMID: 34715496 DOI: 10.1016/j.bbrc.2021.10.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Angelopoulou E, Karlafti E, Georgakopoulou VE, Papalexis P, Papageorgiou SG, Tegos T, Savopoulos C. Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease. Life (Basel) 2023;13. [PMID: 36836893 DOI: 10.3390/life13020536] [Reference Citation Analysis]
2 Huang P, Zhang LY, Tan YY, Chen SD. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener 2023;12:5. [PMID: 36717892 DOI: 10.1186/s40035-023-00337-1] [Reference Citation Analysis]
3 Khan S, Ataullah A, Rahman S, Rahman MM. Vitamin D3 and its necessity for health. Annals of Medicine and Surgery 2022;78:103872. [DOI: 10.1016/j.amsu.2022.103872] [Reference Citation Analysis]
4 Menéndez SG, Martín Giménez VM, Holick MF, Barrantes FJ, Manucha W. COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent. Life Sci 2022;297:120464. [PMID: 35271880 DOI: 10.1016/j.lfs.2022.120464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Fearon C, Fasano A. Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.03.001] [Reference Citation Analysis]